ICH adopts S12 guideline for gene therapies
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyEuropeGlobalNorth AmericaPreclinical studyRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyEuropeGlobalNorth AmericaPreclinical study